Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 10/14/2014
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Pruritus, Rash erythematous
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Prophylaxis
Preexisting Conditions: Varicella, 2-3 years old
Diagnostic Lab Data:
CDC 'Split Type': WAES1407AUS004067
Write-up:Information was obtained on a request by the Company from the agency via a Public Case Detail concerning a Male patient of unkonwn age. Previous varicella disease 2-3 year old. On 24-APR-2014 the patient was vaccinated with GARDASIL dose 1, intramuscular. Other suspect therapies included VARILRIX dose 1. On 30-APR-2014, the patient experienced red spots with white head on back, shoulders and small amount on neck, itchy (disability). School has excluded child for 1 week parent seeking advice. Advised to wait until lesions dry before returning to school. The outcome of the event was reported as not recovered/not resolved. The reporter considered the event to be related to GARDASIL. Additional information is not expected.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166